enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Your Gout Guide: From Symptoms to Treatment - AOL

   www.aol.com/gout-guide-symptoms-treatment...

   The treatment you get for gout can depend on the frequency and severity of your flares. ... According to the American College of Rheumatology guidelines, allopurinol is the first-line medication ...

3. Epaminurad - Wikipedia

   en.wikipedia.org/wiki/Epaminurad

   Epaminurad is an investigational new drug being developed by JW Pharmaceutical for the treatment of gout and hyperuricemia.It is a urate-lowering agent that selectively inhibits the human uric acid transporter 1 (hURAT1), promoting urate excretion.

4. Gout - Wikipedia

   en.wikipedia.org/wiki/Gout

   Gout presenting as slight redness in the metatarsophalangeal joint of the big toe. Gout can present in several ways, although the most common is a recurrent attack of acute inflammatory arthritis (a red, tender, hot, swollen joint). [4] The metatarsophalangeal joint at the base of the big toe is affected most often, accounting for half of cases ...

5. Colchicine - Wikipedia

   en.wikipedia.org/wiki/Colchicine

   Colchicine is a medication used to prevent and treat gout, [3] [4] to treat familial Mediterranean fever [5] and Behçet's disease, [6] and to reduce the risk of myocardial infarction. [7] The American College of Rheumatology recommends colchicine, nonsteroidal anti-inflammatory drugs (NSAIDs) or steroids in the treatment of gout.

6. Managing Out-of-Control Chronic Gout: Going Beyond Oral ...

   www.aol.com/lifestyle/managing-control-chronic...

   The post Managing Out-of-Control Chronic Gout: Going Beyond Oral Treatments appeared first on Reader's Digest. Do you sometimes have severe, unexplained pain in your joints, particularly in your ...

7. Pegloticase - Wikipedia

   en.wikipedia.org/wiki/Pegloticase

   Pegloticase (trade name Krystexxa) is a medication for the treatment of severe, treatment-refractory, chronic gout. It is a third line treatment in those in whom other treatments are not effective or are not tolerated. [2] The drug is administered by infusion intravenously. Since October 2023, Amgen Inc. has been the marketer of pegloticase in ...